Stephen L. Rawlings

Array ( [id] => 6234883 [patent_doc_number] => 20100266587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Compositions and Methods to Treat Acute Myelogenous Leukemia' [patent_app_type] => utility [patent_app_number] => 12/761853 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16499 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266587.pdf [firstpage_image] =>[orig_patent_app_number] => 12761853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6434013 [patent_doc_number] => 20100278838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'EPHA2 MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/755468 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 46589 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278838.pdf [firstpage_image] =>[orig_patent_app_number] => 12755468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097465 [patent_doc_number] => 20110003755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/728363 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32733 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003755.pdf [firstpage_image] =>[orig_patent_app_number] => 12728363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339962 [patent_doc_number] => 20100247529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'COOPERATIVE AND DYNAMIC ASSEMBLY OF AFFINITY COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/727814 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9446 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247529.pdf [firstpage_image] =>[orig_patent_app_number] => 12727814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650870 [patent_doc_number] => 20110300139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'GENERATION, EXPRESSION AND CHARACTERIZATION OF THE HUMANIZED K33N MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/201847 [patent_app_country] => US [patent_app_date] => 2010-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16405 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300139.pdf [firstpage_image] =>[orig_patent_app_number] => 13201847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974137 [patent_doc_number] => 20140377172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'Novel Antibody Recognizing a Small Subset of Human Hematopoietic Cells' [patent_app_type] => utility [patent_app_number] => 12/717660 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12717660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270749 [patent_doc_number] => 20100254987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'ENGINEERED PROTEINS WITH HIGH AFFINITY FOR DOTA CHELATES' [patent_app_type] => utility [patent_app_number] => 12/715162 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23279 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254987.pdf [firstpage_image] =>[orig_patent_app_number] => 12715162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10121458 [patent_doc_number] => 09155805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Monoclonal antibody, and use thereof' [patent_app_type] => utility [patent_app_number] => 13/202330 [patent_app_country] => US [patent_app_date] => 2010-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 15726 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6007034 [patent_doc_number] => 20110059065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-10 [patent_title] => 'FUNCTION AND REGULATION OF ADAMTS-1' [patent_app_type] => utility [patent_app_number] => 12/709296 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21984 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20110059065.pdf [firstpage_image] =>[orig_patent_app_number] => 12709296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656427 [patent_doc_number] => 20110305696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => ' ANTI-SERUM ALBUMIN BINDING VARIANTS' [patent_app_type] => utility [patent_app_number] => 13/202353 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21770 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20110305696.pdf [firstpage_image] =>[orig_patent_app_number] => 13202353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10031501 [patent_doc_number] => 09072798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Specific binding proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/201061 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 154 [patent_figures_cnt] => 237 [patent_no_of_words] => 79085 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13201061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663867 [patent_doc_number] => 20110313136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/148839 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 27392 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313136.pdf [firstpage_image] =>[orig_patent_app_number] => 13148839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228769 [patent_doc_number] => 20100183507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'TUMOR MARKERS IN OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/700311 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15823 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183507.pdf [firstpage_image] =>[orig_patent_app_number] => 12700311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245693 [patent_doc_number] => 20100136017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'DIAGNOSTIC TUMOR MARKERS, DRUG SCREENING FOR TUMORIGENESIS INHIBITION, AND COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/695070 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31280 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136017.pdf [firstpage_image] =>[orig_patent_app_number] => 12695070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432710 [patent_doc_number] => 20100278726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'Modified Antibodies to Prostate-Specific Membrane Antigen and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/692757 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 88386 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278726.pdf [firstpage_image] =>[orig_patent_app_number] => 12692757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536362 [patent_doc_number] => 20100124551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/690846 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28853 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124551.pdf [firstpage_image] =>[orig_patent_app_number] => 12690846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986619 [patent_doc_number] => 20110098219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'System for Curing Hepatic Cancer with Leptin' [patent_app_type] => utility [patent_app_number] => 12/689718 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5225 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098219.pdf [firstpage_image] =>[orig_patent_app_number] => 12689718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7751997 [patent_doc_number] => 08110657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-07 [patent_title] => 'Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein' [patent_app_type] => utility [patent_app_number] => 12/683114 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 14054 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/110/08110657.pdf [firstpage_image] =>[orig_patent_app_number] => 12683114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650869 [patent_doc_number] => 20110300138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'HUMAN ANTI TSHR ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/142217 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 162 [patent_figures_cnt] => 162 [patent_no_of_words] => 79194 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300138.pdf [firstpage_image] =>[orig_patent_app_number] => 13142217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9482791 [patent_doc_number] => 08728740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (B-FN) for diagnosis or therapy' [patent_app_type] => utility [patent_app_number] => 13/139112 [patent_app_country] => US [patent_app_date] => 2009-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1620 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139112 [rel_patent_id] =>[rel_patent_doc_number] =>)